135 related articles for article (PubMed ID: 1481722)
1. The effect of transforming growth factor beta on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63.
Fawthrop FW; Oyajobi BO; Bunning RA; Russell RG
J Bone Miner Res; 1992 Dec; 7(12):1363-71. PubMed ID: 1481722
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells.
Allan EH; Zeheb R; Gelehrter TD; Heaton JH; Fukumoto S; Yee JA; Martin TJ
J Cell Physiol; 1991 Oct; 149(1):34-43. PubMed ID: 1834680
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen-dependent activation of latent transforming growth factor beta (TGF beta) by growing cultures of osteoblast-like cells.
Yee JA; Yan L; Dominguez JC; Allan EH; Martin TJ
J Cell Physiol; 1993 Dec; 157(3):528-34. PubMed ID: 8253864
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
Allan EH; Martin TJ
J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator regulation in osteoblasts: parathyroid hormone inhibition of type-1 plasminogen activator inhibitor and its mRNA.
Fukumoto S; Allan EH; Yee JA; Gelehrter TD; Martin TJ
J Cell Physiol; 1992 Aug; 152(2):346-55. PubMed ID: 1322417
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta 1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor.
Falcone DJ; McCaffrey TA; Haimovitz-Friedman A; Garcia M
J Cell Physiol; 1993 Jun; 155(3):595-605. PubMed ID: 7684044
[TBL] [Abstract][Full Text] [Related]
7. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
8. THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor.
Falcone DJ; McCaffrey TA; Mathew J; McAdam K; Borth W
J Cell Physiol; 1995 Aug; 164(2):334-43. PubMed ID: 7622580
[TBL] [Abstract][Full Text] [Related]
9. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
10. Modulation of urokinase-type plasminogen activator gene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8.
Niiya K; Shinbo M; Ozawa T; Hayakawa Y; Sakuragawa N
Thromb Haemost; 1995 Dec; 74(6):1511-5. PubMed ID: 8772229
[TBL] [Abstract][Full Text] [Related]
11. Growth factors mediate glucocorticoid receptor function and dexamethasone-induced regression of osteoblastic lesions in hormone refractory prostate cancer.
Koutsilieris M; Reyes-Moreno C; Sourla A; Dimitriadou V; Choki I
Anticancer Res; 1997; 17(3A):1461-5. PubMed ID: 9179184
[TBL] [Abstract][Full Text] [Related]
12. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-beta to TGF-beta.
Odekon LE; Blasi F; Rifkin DB
J Cell Physiol; 1994 Mar; 158(3):398-407. PubMed ID: 8126064
[TBL] [Abstract][Full Text] [Related]
13. Opposing effects of interleukin-1 and transforming growth factor-beta on the regulation of tissue-type plasminogen activator and plasminogen activator inhibitor type-1 expression by human mesangial cells.
Wilson HM; Haites NE; Booth NA
Exp Nephrol; 1997; 5(3):233-8. PubMed ID: 9208283
[TBL] [Abstract][Full Text] [Related]
14. Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.
Mars WM; Kim TH; Stolz DB; Liu ML; Michalopoulos GK
Cancer Res; 1996 Jun; 56(12):2837-43. PubMed ID: 8665523
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts.
Hilal G; Martel-Pelletier J; Pelletier JP; Duval N; Lajeunesse D
Arthritis Rheum; 1999 Oct; 42(10):2112-22. PubMed ID: 10524682
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor induction of urokinase-type plasminogen activator in human endothelial cells.
Niedbala MJ; Stein M
Biomed Biochim Acta; 1991; 50(4-6):427-36. PubMed ID: 1801706
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human bone morphogenetic protein-2 enhances expression of interleukin-6 and transforming growth factor-beta 1 genes in normal human osteoblast-like cells.
Zheng MH; Wood DJ; Wysocki S; Papadimitriou JM; Wang EA
J Cell Physiol; 1994 Apr; 159(1):76-82. PubMed ID: 8138593
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous stimulation of urokinase and tissue-type plasminogen activators by phorbol esters in human ovarian carcinoma cells.
Band V; Karlan BY; Zurawski VR; Littlefield BA
J Cell Physiol; 1989 Jan; 138(1):106-14. PubMed ID: 2492025
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta stimulates urokinase expression in tumor-associated macrophages of the breast.
Hildenbrand R; Jansen C; Wolf G; Böhme B; Berger S; von Minckwitz G; Hörlin A; Kaufmann M; Stutte HJ
Lab Invest; 1998 Jan; 78(1):59-71. PubMed ID: 9461122
[TBL] [Abstract][Full Text] [Related]
20. TGF-beta regulation of nuclear proto-oncogenes and TGF-beta gene expression in normal human osteoblast-like cells.
Subramaniam M; Oursler MJ; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1995 Jan; 57(1):52-61. PubMed ID: 7721958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
